Dr DeBernardo on the Role of PARP Inhibitors in Frontline Ovarian Cancer
Robert DeBernardo, MD, discusses the current role of PARP inhibitors in the frontline treatment landscape in ovarian cancer.
Source: onclive.com
Peritoneal Surface Malignancy Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Peritoneal Surface Malignancy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Peritoneal Surface Malignancy Program Today - Breaking & Trending Today